 |
|
Human Immunodeficiency Virus Early Intervention Physician Guidelines, Second Edition
Advisory Group on HIV Early Intervention, Second Edition, American Medical Association
Arch Fam Med. 1994;3(11):988-1002.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
1. Centers for Disease Control and Prevention. Projections of the number of persons diagnosed with AIDS and the number of immunosuppressed HIV-infected persons: United States, 1992-1994. MMWR Morb Mortal Wkly Rep. 1992;41(RR-18):1-29.
PUBMED
2. American Academy of Family Physicians. The Family Physician's Guide to HIV Infection and AIDS. Kansas City, Mo: American Academy of Family Physicians; 1990. 3. AZT therapy for early HIV infection. Clin Courier. 1990;8:1-8.
4. Staver S. AIDS expert says physicians can learn to treat with AZT. Am Med News. April 13, 1990:6-7. 5. Vermund SH, Galbraith MA, Ebner SC, et al. Human immunodeficiency virus/acquired immunodeficiency syndrome in pregnant women. Ann Epidemiol. 1992;2:773-803.
PUBMED
6. Centers for Disease Control and Prevention. Zidovudine for the prevention of HIV transmission from mother to infant. MMWR Morb Mortal Wkly Rep. 1994;43:285-287.
PUBMED
7. Jewell ME, Jewell GS. How to assess the risk of HIV exposure. Am Fam Physician. 1989;40:153-161.
PUBMED
8. Centers for Disease Control and Prevention. Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings. MMWR Morb Mortal Wkly Rep. 1993;42:157-158.
PUBMED
9. Bresolin LB, Rinaldi RC. HIV Blood Test Counseling: Physician Guidelines. 2nd ed. Chicago, Ill: American Medical Association; 1993. 10. Perry SW, Markowitz JC. Counseling for HIV testing. Hosp Community Psychiatry. 1988;39:731-739.
PUBMED
11. Hockings J. AIDS counselling in the context of the Terrence Higgins Trust. Counselling Psychol. 1989;2:3-91.
12. Centers for Disease Control and Prevention. Technical guidance on HIV counseling. MMWR Morb Mortal Wkly Rep. 1993;42(RR-2):8-17.
13. Centers for Disease Control. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR Morb Mortal Wkly Rep. 1987;36:509-515.
PUBMED
14. Kunins H, Hein K, Futterman D, Tapley E, Elliot AS. Guide to adolescent HIV/AIDS program development. J Adolesc Health. 1993;14(suppl):1-140.
PUBMED
15. Gerber AR, Valdiserri RO, Holtgrave DR, et al. Preventive services guidelines for primary care clinicians caring for adults and adolescents infected with the human immunodeficiency virus. Arch Fam Med. 1993;2:969-979.
FREE FULL TEXT
16. Centers for Disease Control and Prevention. Technical guidance on HIV counseling. MMWR Morb Mortal Wkly Rep. 1993;42(RR-2):11-17.
17. Centers for Disease Control and Prevention, Centers for Substance Abuse Treatment, National Institute on Drug Abuse. HIV/AIDS Prevention Bulletin. Atlanta, Ga: Centers for Disease Control and Prevention; 1993. 18. Centers for Disease Control and Prevention. Use of bleach for disinfection of drug injection equipment. MMWR Morb Mortal Wkly Rep. 1993;42:418-419.
PUBMED
19. Isaacman SH, Closen ML. Notifying contacts of HIV-infected patients. Postgrad Med. 1989;85:42, 44, 53-55, 59.
PUBMED
20. Foundation for Children With AIDS. National Pediatric HIV Resource Center criteria for the initiation of antiretroviral therapy. Child AIDS. 1993;5:7.
21. English A. Expanding access to HIV services for adolescents: legal and ethical issues. In: DiClemente RJ, ed. Adolescents and AIDS: A Generation in Jeopardy. Newbury Park, Calif: Sage Publishers Inc; 1992:262-283. 22. Futterman D, Hein K. Medical care of HIV-infected adolescents. AIDS Clin Care. 1992;4:95-98.
23. Goldschmidt RH. Current report—HIV: laboratory testing for the presence of HIV infection and the progression of HIV disease. J Am Board Fam Pract. 1990;3:60-62.
PUBMED
24. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41(RR-17):1-19.
PUBMED
25. Redfield RR, Tramont ET. Toward a better classification system for HIV infection. N Engl J Med. 1989;320:1414-1416.
PUBMED
26. Gordon S. Seroconversion, staging and survival. J Am Podiatr Med Assoc. 1990;80:9-15.
ABSTRACT
27. Redfield RR, Wright DC, Tramont ET. The Walter Reed staging classification for HTLV-Ill/LAV infection. N Engl J Med. 1986;314:131-132.
PUBMED
28. Abrams DI. Alternative therapies. In: Rapoza N, ed. HIV Infection and Disease. Chicago, Ill: American Medical Association; 1989:163-175. 29. Freedman B. Nonvalidated therapies and HIV disease. Hastings Cent Rep. 1989;19:14-20.
PUBMED
30. Glazier RE, Glazier DM. A Primer on Alternative Therapies, Holistic Medicine, and HIV Disease. Cambridge, Mass: Abt Associates Inc; 1989. 31. Hecht FM, Jewett J, Bateman WB. Management of human immunodeficiency virus in the seropositive, asymptomatic patient. In: Holmes K, ed. AIDS: Treatment and Diagnosis. New York, NY: McGraw Hill International Book Co; 1990: 92-106. 32. Fink BK, Katz MH, Hernandez SR. The case of asymptomatic HIV-infected patients. West J Med. 1989;151:464-466.
PUBMED
33. Janssen RS, Saykin AJ, Cannon L, et al. Neurological and neuropsychological manifestations of HIV-1 infection: association with AIDS-related complex but not asymptomatic HIV-1 infection. Ann Neurol. 1989;26:592-600.
PUBMED
34. Harter DH. Neuropsychological status of asymptomatic individuals seropositive to HIV-1. Ann Neurol. 1989;26:589-591.
PUBMED
35. Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence. MMWR Morb Mortal Wkly Rep. 1993;42(RR-5):1-18.
PUBMED
36. Martini E, Muller J, Doinel C, et al. Disappearance of CD4-lymphocyte circadian cycles in HIV-infected patients: early events during asymptomatic infection. AIDS. 1988;2:133-134.
PUBMED
37. Koepke JA, Landay AL. Precision and accuracy of absolute lymphocyte counts. Clin Immunol Immunopathol. 1989;52:19-27.
PUBMED
38. Centers for Disease Control and Prevention. Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection. MMWR Morb Mortal Wkly Rep. 1992;41(RR-8):1-17.
PUBMED
39. Anderson RE, Lang W, Shiboski S, et al. Use of beta2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection. Arch Intern Med. 1990;150:73-77.
FREE FULL TEXT
40. Conant M. Early intervention and management of HIV infection. Transcript. February 1992:13-16. 41. Seligman N, Warrell DA, Aboulken J-P, et al. Concorde: MRC/ANRS randomized double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet. 1994;343:871-881.
PUBMED
42. National Institute of Allergy and Infectious Diseases. Preliminary guidelines take more patient-tailored approach to HIV therapy. NIAID AIDS Agenda. Summer 1993:1;11-12.
PUBMED
43. Working Group on Antiretroviral Therapy. Antiretroviral Therapy and Medical Management of the HIV-Infected Child. Newark, NJ: National Pediatric HIV Resource Center; 1992. 44. Amadori A, De Rossi A, Chieco-Bianchi L. Diagnosis of human immunodeficiency virus 1 infection in infants: in vitro production of virus-specific antibodies in lymphocytes. Pediatr Infect Dis J. 1990;9:26-30.
PUBMED
45. Volberding PA, Lagakos SW, Koch MA. Zidovudine in asymptomatic human immunodeficiency virus infection. N Engl J Med. 1990;322:941-949.
PUBMED
46. Miller-Catchpole R, Rapoza NP. Prophylactic treatment for opportunistic infections in HIV-positive patients: aerosolized pentamidine. JAMA. 1990;263:2510-2514.
FREE FULL TEXT
47. Phair J, Munozo A, Detels R, et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med. 1990;322:161-165.
PUBMED
48. Centers for Disease Control and Prevention. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1992;41(RR-4):1-11.
PUBMED
49. Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1991;40:RR-2.
50. US Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex. MMWR Morb Mortal Wkly Rep. 1993;42(RR-9):13-19.
51. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. N Engl J Med. 1993;329:898-904.
PUBMED
52. Centers for Disease Control and Prevention. Management of persons exposed to multidrug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep. 1992;41 (RR-11):59-71.
53. American Thoracic Society. Diagnosis standards and classification of tuberculosis. Am Rev Respir Dis. 1990;142:725-735.
PUBMED
54. Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1993;42(RR-7):1-8.
PUBMED
55. Centers for Disease Control. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR Morb Mortal Wkly Rep. 1991;4 (RR-5):27-33.
56. Canessa PA, Fasano L, Lavecchia MA, et al. Tuberculin skin test in asymptomatic HIV seropositive carriers. Chest. 1989;96:1215-1216.
PUBMED
57. Centers for Disease Control. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR Morb Mortal Wkly Rep. 1989;38:243-250.
58. Barnes PF, Bloch AB, Davidson PT, et al. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991;324:1644-1650.
PUBMED
59. Kramer F, Modilevsky T, Waliany AR, et al. Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med. 1990;89:451-456.
PUBMED
60. Centers for Disease Control. Screening for tuberculosis and tuberculosis infection in high-risk populations and the use of preventive therapy for tuberculosis infection in the United States: recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1990;39(RR-8):1-12.
PUBMED
61. American Thoracic Society. Control of tuberculosis in the United States. Am Rev Respir Dis. 1992;148:1623-1633.
62. Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR Morb Mortal Wkly Rep. 1990;39(RR-17):1-29.
PUBMED
63. Raiten DJ. Nutrition and HIV Infection: A Review and Evaluation of the Extant Knowledge of the Relationship Between Nutrition and HIV Infection. Bethesda, Md: Life Science Research Office of the Federation of American Societies for Experimental Biology; 1990. 64. Abrams B, Duncan D, Hertz-Picciotto I. A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men. J Acquir Immune Defic Syndr. 1993;6:949-958.
PUBMED
65. Striepe MI, Benak MA. Nutritional management of HIV infection. In: Mukand J, ed. Rehabilitation for Patients With HIV Disease. New York, NY: McGraw-Hill International Book Co; 1991:161-177. 66. Odeh M. The role of zinc in acquired immunodeficiency syndrome. J Intern Med. 1992;231:463-469.
PUBMED
67. Beach RS, Morgan R, Wilkie F, et al. Plasma vitamin B12 level as a potential cofactor in studies of human immunodeficiency virus type 1-related cognitive changes. Arch Neurol. 1992;49:510-506.
68. Kieburtz KD, Giang DW, Schiffer RB, et al. Abnormal vitamin B12 metabolism in human immunodeficiency virus infection: association with neurological dysfunction. Arch Neurol. 1991;48:312-314.
FREE FULL TEXT
69. Baum MK, Mantero-Atienza E, Shor-Posner G, et al. Association of vitamin B6 status with parameters of immune function in early HIV-1 infection. J Acquir Immune Defic Syndr. 1991;4:1122-1132.
PUBMED
70. Moseson M, Zeleniuch-Jacquotte A, Belsito DV, et al. The potential role of nutritional factors in the induction of immunologic abnormalities in HIV-positive homosexual men. J Acquir Immune Defic Syndr. 1989;2:235-247.
PUBMED
71. Baum MK, Shor-Posner G, Bonvehi PE, et al. Interim dietary recommendations to maintain adequate blood nutrient levels in early HIV-1 infection. In: Program and abstracts of the 8th International Conference on AIDS; July 19-24; Amsterdam, the Netherlands. Abstract PoB 3675. 72. Semba RD, Graham NMH, Caiaffa WT, et al. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med. 1993;153:2149-2154.
FREE FULL TEXT
73. Channing L Bete Co. Living With HIV. South Deerfield, Mass: Channing L Beten Co; 1990.
|
